Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Equity (2017 - 2025)

Historic Return on Equity for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to 0.27%.

  • Puma Biotechnology's Return on Equity fell 1200.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.32% for FY2024, which is 2600.0% down from last year.
  • Latest data reveals that Puma Biotechnology reported Return on Equity of 0.27% as of Q3 2025, which was down 1200.0% from 0.41% recorded in Q2 2025.
  • Puma Biotechnology's Return on Equity's 5-year high stood at 4.34% during Q4 2021, with a 5-year trough of 20.84% in Q1 2022.
  • Moreover, its 5-year median value for Return on Equity was 0.2% (2023), whereas its average is 1.45%.
  • Per our database at Business Quant, Puma Biotechnology's Return on Equity crashed by -157800bps in 2022 and then soared by 210400bps in 2023.
  • Puma Biotechnology's Return on Equity (Quarter) stood at 4.34% in 2021, then plummeted by -100bps to 0.0% in 2022, then skyrocketed by 512401bps to 0.47% in 2023, then plummeted by -39bps to 0.28% in 2024, then dropped by -4bps to 0.27% in 2025.
  • Its Return on Equity stands at 0.27% for Q3 2025, versus 0.41% for Q2 2025 and 0.33% for Q1 2025.